VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 106 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $268,204 | -88.4% | 34,607 | -82.8% | 0.00% | -100.0% |
| Q2 2023 | $2,302,274 | +260.3% | 201,072 | +235.4% | 0.00% | – |
| Q3 2020 | $639,000 | -15.5% | 59,944 | +0.1% | 0.00% | – |
| Q2 2020 | $756,000 | -1.8% | 59,891 | -28.8% | 0.00% | – |
| Q1 2020 | $770,000 | -30.6% | 84,107 | +5.7% | 0.00% | – |
| Q4 2019 | $1,110,000 | -83.6% | 79,604 | -79.8% | 0.00% | -100.0% |
| Q3 2019 | $6,773,000 | -40.9% | 393,555 | -6.6% | 0.00% | -33.3% |
| Q2 2019 | $11,464,000 | +957.6% | 421,155 | +643.6% | 0.00% | – |
| Q1 2019 | $1,084,000 | +19.0% | 56,639 | -41.6% | 0.00% | – |
| Q4 2018 | $911,000 | +251.7% | 96,909 | +630.3% | 0.00% | – |
| Q2 2018 | $259,000 | -73.4% | 13,269 | -77.4% | 0.00% | – |
| Q4 2017 | $974,000 | – | 58,685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
| Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
| GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
| BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
| Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
| Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
| Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
| Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
| THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |